147
Participants
Start Date
January 31, 2005
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
voriconazole (Vfend)
voriconazole, early treatment
voriconazole (Vfend)
voriconazole, deferred treatment
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Berlin
Pfizer Investigational Site, Potsdam
Pfizer Investigational Site, Frankfurt (Oder)
Pfizer Investigational Site, Lübeck
Pfizer Investigational Site, Kiel
Pfizer Investigational Site, Bremen
Pfizer Investigational Site, Hanover
Pfizer Investigational Site, Bielefeld
Pfizer Investigational Site, Göttingen
Pfizer Investigational Site, Essen
Pfizer Investigational Site, Cologne
Pfizer Investigational Site, Trier
Pfizer Investigational Site, Mainz
Pfizer Investigational Site, Wiesbaden
Pfizer Investigational Site, Homburg/Saar
Pfizer Investigational Site, Ludwigshafen
Pfizer Investigational Site, Stuttgart
Pfizer Investigational Site, Freiburg im Breisgau
Pfizer Investigational Site, München
Pfizer Investigational Site, München
Pfizer Investigational Site, Augsburg
Pfizer Investigational Site, Erlangen
Pfizer Investigational Site, Würzburg
Pfizer Investigational Site, Chemnitz
Pfizer Investigational Site, Dresden
Pfizer Investigational Site, Leipzig
Lead Sponsor
Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
UNKNOWN
Pfizer
INDUSTRY